Correlation Between MBX Biosciences, and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MBX Biosciences, and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MBX Biosciences, and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MBX Biosciences, Common and Milestone Pharmaceuticals, you can compare the effects of market volatilities on MBX Biosciences, and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MBX Biosciences, with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MBX Biosciences, and Milestone Pharmaceuticals.
Diversification Opportunities for MBX Biosciences, and Milestone Pharmaceuticals
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between MBX and Milestone is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding MBX Biosciences, Common and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and MBX Biosciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MBX Biosciences, Common are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of MBX Biosciences, i.e., MBX Biosciences, and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between MBX Biosciences, and Milestone Pharmaceuticals
Considering the 90-day investment horizon MBX Biosciences, Common is expected to generate 1.82 times more return on investment than Milestone Pharmaceuticals. However, MBX Biosciences, is 1.82 times more volatile than Milestone Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 1,600 in MBX Biosciences, Common on September 3, 2024 and sell it today you would earn a total of 434.00 from holding MBX Biosciences, Common or generate 27.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 11.52% |
| Values | Daily Returns |
MBX Biosciences, Common vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| MBX Biosciences, Common |
| Milestone Pharmaceuticals |
MBX Biosciences, and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MBX Biosciences, and Milestone Pharmaceuticals
The main advantage of trading using opposite MBX Biosciences, and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MBX Biosciences, position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| MBX Biosciences, vs. DiaMedica Therapeutics | MBX Biosciences, vs. Lyra Therapeutics | MBX Biosciences, vs. Centessa Pharmaceuticals PLC |
| Milestone Pharmaceuticals vs. DiaMedica Therapeutics | Milestone Pharmaceuticals vs. Lyra Therapeutics | Milestone Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Transaction History View history of all your transactions and understand their impact on performance |